Blood pressure in early autosomal dominant polycystic kidney disease.

[1]  W. Elliott.  Meta-analysis: Effect of Monotherapy and Combination Therapy with Inhibitors of the Renin–Angiotensin System on Proteinuria in Renal Disease , 2009 .

[2]  Michael Böhm,et al.  2013 ESH/ESC Guidelines for the management of arterial hypertension , 2007, Blood pressure.

[3]  Nish Chaturvedi,et al.  Cardiorenal end points in a trial of aliskiren for type 2 diabetes. , 2012, The New England journal of medicine.

[4]  E. Murphy,et al.  Progression of aortic dilatation and the benefit of long-term beta-adrenergic blockade in Marfan's syndrome. , 1994, The New England journal of medicine.

[5]  Kaleab Z. Abebe,et al.  Blood pressure in early autosomal dominant polycystic kidney disease. , 2014, The New England journal of medicine.

[6]  H. Connolly,et al.  Of Marfan's syndrome, mice, and medications. , 2014, The New England journal of medicine.

[7]  S. Bangalore,et al.  Efficacy and safety of dual blockade of the renin-angiotensin system: meta-analysis of randomised trials , 2013, BMJ.

[8]  Kaleab Z. Abebe,et al.  Angiotensin blockade in late autosomal dominant polycystic kidney disease. , 2014, The New England journal of medicine.

[9]  W. Cushman,et al.  Blood Pressure and Mortality in U.S. Veterans With Chronic Kidney Disease , 2013, Annals of Internal Medicine.

[10]  R. Schrier,et al.  Appropriate Blood Pressure Control in type II diabetes (ABCD Trial): implications for complications. , 1992, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[11]  S. Colan,et al.  Atenolol versus losartan in children and young adults with Marfan's syndrome. , 2014, The New England journal of medicine.

[12]  S. Yusuf,et al.  Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial , 2008, The Lancet.

[13]  R. Hui,et al.  The effect of beta‐blocker therapy on progressive aortic dilatation in children and adolescents with Marfan’s syndrome: a meta‐analysis , 2011, Acta paediatrica.

[14]  Zhezhen Jin,et al.  The effect of beta-blocker therapy on clinical outcome in patients with Marfan's syndrome: a meta-analysis. , 2007, International journal of cardiology.